Short Courses*

MONDAY, AUGUST 20 | Morning, 9:00 am - 12:00 pm

SC1: Liquid Biopsy: Technology, Applications, Regulations and Reimbursement - (Arlington) Detailed Agenda

Hatim Husain, MD, Physician, Medical Oncology, University of California, San Diego

John Simmons, PhD, Director, Translational Science & Diagnostics, Personal Genome Diagnostics

Živana Težak, PhD, Associate Director for Science and Technology, Office of In Vitro Diagnostics and Radiological Health (OIR), CDRH/FDA
Girish Putcha, MD, PhD, Director of Laboratory Science, MolDx, Palmetto GBA

SC4: Technologies, Applications and Commercialization of Point-of-Care Diagnostics -(Cabin John) Detailed Agenda

Holger Becker, PhD, Founder & CSO, microfluidic ChipShop GmbH

TUESDAY, AUGUST 21 | Dinner, 6:45 - 9:15 pm

SC6: Rapid Diagnostics for Antimicrobial Stewardship -(Arlington) Detailed Agenda

Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Associate Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California

April Abbott, PhD, D(ABMM), Director, Microbiology, Deaconess Health System

Amanda Harrington, PhD, Associate Professor, Pathology; Medical Director, Microbiology, Loyola University Medical Center

SC7: Practical Considerations for NGS Data Analysis and Interpretation - (Cabin John) Detailed Agenda

Robert D. Daber, PhD, President and CTO, Genosity 

Matthew Lebo, PhD, FACMG, Director, Bioinformatics, Partners Personalized Medicine; Instructor, Pathology, Brigham and Women’s and Harvard Medical School

THURSDAY, AUGUST 23 | Dinner, 6:30 - 9:00 pm

SC9: Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization - (Arlington) Detailed Agenda

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc

Marta Fernandez Suarez, Daktari Diagnostics & FIND

Kris Buchanan, CEO, Phase Three Product Development 

Evan F Cromwell, President & CEO, Protein Fluidics  

SC10: Leveraging Key Opinion Leaders (KOLs): Building a Bridge Between R&D and Commercialization of Companion and Non-Companion Diagnostics - (Cabin John) Detailed Agenda

Lawrence J. Worden, Principal, IVD Logix

Charles Mathews, Principal, ClearView Healthcare Partners

Peggy Robinson, Vice President, Angle PLC

*Separate registration required for Short Courses.